BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11967540)

  • 1. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation.
    Inlay M; Alt FW; Baltimore D; Xu Y
    Nat Immunol; 2002 May; 3(5):463-8. PubMed ID: 11967540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intronic immunoglobulin kappa gene enhancer acts independently on rearrangement and on transcription.
    Kallenbach S; Babinet C; Pournin S; Cavelier P; Goodhardt M; Rougeon F
    Eur J Immunol; 1993 Aug; 23(8):1917-21. PubMed ID: 8344354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variegated transcriptional activation of the immunoglobulin kappa locus in pre-b cells contributes to the allelic exclusion of light-chain expression.
    Liang HE; Hsu LY; Cado D; Schlissel MS
    Cell; 2004 Jul; 118(1):19-29. PubMed ID: 15242641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
    Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
    J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa and lambda rearrangement occur simultaneously in transformed pre-B cells.
    Liu D; Jenab J; Rosenberg N
    J Immunol; 1997 Dec; 159(12):6061-9. PubMed ID: 9550405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the Igkappa gene MAR regulates the probability of premature V-J joining and somatic hypermutation.
    Yi M; Wu P; Trevorrow KW; Claflin L; Garrard WT
    J Immunol; 1999 May; 162(10):6029-39. PubMed ID: 10229843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes.
    Gorman JR; van der Stoep N; Monroe R; Cogne M; Davidson L; Alt FW
    Immunity; 1996 Sep; 5(3):241-52. PubMed ID: 8808679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
    Inlay MA; Lin T; Gao HH; Xu Y
    J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombining sequence recombination in normal kappa-chain-expressing B cells.
    Dunda O; Corcos D
    J Immunol; 1997 Nov; 159(9):4362-6. PubMed ID: 9379033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus.
    Fraenkel S; Mostoslavsky R; Novobrantseva TI; Pelanda R; Chaudhuri J; Esposito G; Jung S; Alt FW; Rajewsky K; Cedar H; Bergman Y
    Nat Immunol; 2007 Jul; 8(7):715-22. PubMed ID: 17546032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of enhancer sequences 3' of the rabbit Ig kappa L chain loci.
    Hole NJ; Harindranath N; Young-Cooper GO; Garcia R; Mage RG
    J Immunol; 1991 Jun; 146(12):4377-84. PubMed ID: 1904082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans.
    Takeda S; Zou YR; Bluethmann H; Kitamura D; Muller U; Rajewsky K
    EMBO J; 1993 Jun; 12(6):2329-36. PubMed ID: 8508766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes.
    Chen C; Birshtein BK
    J Immunol; 1997 Aug; 159(3):1310-8. PubMed ID: 9233627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa chain monoallelic demethylation and the establishment of allelic exclusion.
    Mostoslavsky R; Singh N; Kirillov A; Pelanda R; Cedar H; Chess A; Bergman Y
    Genes Dev; 1998 Jun; 12(12):1801-11. PubMed ID: 9637682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement.
    Xu Y; Davidson L; Alt FW; Baltimore D
    Immunity; 1996 Apr; 4(4):377-85. PubMed ID: 8612132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearrangement-enhancing element upstream of the mouse immunoglobulin kappa chain J cluster.
    Ferradini L; Gu H; De Smet A; Rajewsky K; Reynaud CA; Weill JC
    Science; 1996 Mar; 271(5254):1416-20. PubMed ID: 8596914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.